Sign in

You're signed outSign in or to get full access.

Jane Morreau

Director at Trulieve Cannabis
Board

About Jane Morreau

Jane C. Morreau, 66, has served as an independent director of Trulieve Cannabis Corp. since 2021 and is a member of the Audit Committee. She is a seasoned global finance executive and CPA, formerly Executive Vice President and Chief Financial Officer of Brown‑Forman Corporation (2014–2021), with prior finance roles at Kentucky Fried Chicken (Yum! Brands). She holds a B.S. in Accounting (with high honors) and an MBA from the University of Louisville and has been designated by the Board as an audit committee financial expert .

Past Roles

OrganizationRoleTenureCommittees/Impact
Brown‑Forman CorporationExecutive Vice President & CFO2014–2021Led global finance; broad expertise in supply chain, manufacturing operations, IT, retail ops, M&A, corporate strategy
Brown‑Forman CorporationSenior management/executive finance roles1991–201430-year career with escalating finance/operational leadership
Kentucky Fried Chicken (Yum! Brands)Finance rolesPre‑1991Various financial roles

External Roles

OrganizationPublic/PrivateRoleStartCommittees
Vita CocoPublicDirector; Chair of Audit; Member of Nominating & ESG2021Audit (Chair); Nominating; ESG
Del Monte Foods Holdings LimitedPrivateDirectorJun 2023Audit; Nominating
Ole Smoky DistilleryPrivateDirectorJul 2023Board member
Public company boards (ex‑Trulieve)Count1
Private company boards (ex‑Trulieve)Count2

Board Governance

  • Independence: Independent under NI 52‑110; Audit Committee financial expert .
  • Committee assignments: Audit Committee member; Audit chaired by Thomas Millner; other members Peter Healy and Susan Thronson .
  • Attendance and engagement: Board met 9 times in 2024; each director attended ≥75% of board and applicable committee meetings; annual meeting attendance by all directors . Audit Committee met 9 times in 2024 .
  • Board leadership: CEO (Kim Rivers) is Chair; lead independent director structure in place (Peter Healy) with defined duties and independent executive sessions at regular meetings .

Fixed Compensation

Component2024 ValueNotes
Annual cash retainer$75,000Standard for non‑employee directors
Chair/lead retainers (program terms)$25,000 Lead Director; $20,000 Audit Chair; $15,000 Comp Chair; $12,500 Nominating ChairMorreau is not a chair at Trulieve; no incremental chair fee
Fees earned in cash (Morreau)$75,0002024 Director Compensation Table
Stock ownership guidelines3× annual cash retainer (non‑executive directors)Adopted after 2023 review; in effect by 2025 proxy; individual compliance not disclosed
Non‑employee director annual grant cap$750,000 (cash + grant‑date fair value)Plan limit; exceptions only in extraordinary circumstances; conflicted director may not participate in the decision

Performance Compensation

Equity Component2024 GrantGrant‑Date Fair ValueVesting/Status
RSUs (Morreau)7,500 units$75,000As of 12/31/2024, RSUs vested but remained outstanding pending settlement
Stock options (Morreau)13,580 options$68,036As of 12/31/2024, options vested
Director equity program (general)~50% options / ~50% RSUs~$150,000 total target per yearCompetitive retention and alignment; initial and annual grants; at‑market options; 10‑year max term; no repricing without shareholder approval

Performance metrics: None disclosed for director compensation; equity is time‑based and not tied to revenue/EBITDA/TSR targets .

Other Directorships & Interlocks

  • Network: Beverage and spirits boards (Vita Coco; Del Monte Foods Holdings Limited; Ole Smoky Distillery) may enhance consumer brand, supply chain, and retail oversight skills; no related‑party transactions disclosed involving Morreau at Trulieve .
  • Interlocks: No compensation committee interlocks or insider participation involving Morreau; 2024 comp committee members were independent, none were Trulieve officers .

Expertise & Qualifications

  • Skills (Board matrix): Public company finance experience; retail experience; M&A experience; independent director; financial expert designation .
  • Education/credentials: B.S. Accounting (high honors), MBA (University of Louisville); CPA .
  • Age and tenure: 66 as of 4/11/2025; director since 2021; years of service 4 .

Equity Ownership

HoldingAmountNotes
Subordinate Voting Shares beneficially owned95,513<1% ownership
Multiple Voting Shares0
Options exercisable within 60 days90,786Included in beneficial ownership calculation rules
RSUs (deferred settlement feature)19,003Settlement no later than 30 days after earlier of separation, qualifying change‑in‑control, or award anniversary date (Dec 1, 2030 or Dec 1, 2031)
  • Hedging/pledging: Company policy prohibits hedging or short sales; pledging not disclosed .
  • Section 16 compliance: Company indicates officers/directors timely filed required Section 16(a) reports for 2024 .

Governance Assessment

  • Board effectiveness: Morreau strengthens audit oversight (financial expert, multi‑industry finance background). Audit Committee met 9 times and oversees financial reporting, controls, risk, and cybersecurity; her Vita Coco audit chair role adds relevant governance depth .
  • Independence and attendance: Independent; attended at least 75% of meetings; supports investor confidence in board engagement .
  • Alignment and pay structure: Director compensation mix emphasizes equity (~$143k of $218k total for 2024), aligning interests; ownership guidelines (3× retainer) add discipline, but individual compliance status is not disclosed .
  • Conflicts/related parties: No Morreau‑specific related‑party transactions disclosed. Company discloses leases and agreements involving the CEO and director Richard May; oversight of related‑party reviews sits with Nominating & Corporate Governance Committee; policies require review/approval and consider arm’s‑length terms .
  • Risk indicators and signals:
    • CEO dual role as Chair is a governance risk; mitigated by independent Lead Director, executive sessions, and committee independence .
    • CFO resigned effective March 2025—heightened importance of Audit Committee oversight during transition; board updated policies/code after prior CFO investigation in 2023 .
    • Say‑on‑pay: 86.6% approval in 2024 indicates shareholder support for compensation practices; continued monitoring warranted given sector volatility .
    • Equity plan protections: No evergreen; no repricing without shareholder approval; double‑trigger CIC vesting; clawback provisions subject to recoupment policy—positive governance features .

RED FLAGS: None disclosed specific to Morreau (no related‑party exposure, no attendance issues, no Section 16 delinquencies). Company‑level considerations include CEO as Chair and related‑party leases with CEO/another director, which place added importance on independent oversight and committee rigor .